INABIS '98 Home Page | Your Session | Symposia & Poster Sessions | Plenary Sessions | Exhibitors' Foyer | Personal Itinerary | New Search |
Invited Symposium
|
Angiotensin ReceptorsChair: Emanuel Escher (University of Sherbrooke, Canada) |
0298
Regulation of AT1 Angiotensin Receptor Gene Expression in Vascular Smooth Muscle Cells
TJ Murphy (Department of Pharmacology, Emory University School of Medicine, USA) |
0607
Induced Fit as a Mechanism of Specificity in the AT1 Receptor Activation by Angiotensin II
S-I. Miura (The Cleveland Clinic, Cleveland, USA) Y-H. Feng (The Cleveland Clinic, Cleveland, USA) K. Noda (The Cleveland Clinic, Cleveland, USA) A. Husain (The Cleveland Clinic, Cleveland, USA) S. Karnik (The Cleveland Clinic, Cleveland, USA) |
0625
Molecular Modeling and Mutagenesis Studies of Angiotensin II/AT1 Interaction and Signal Transduction
A.C.M. Paiva (Department of Biophysics, Federal University of Sao Paulo, Brazil) C.M. Costa-Neto (Department of Biophysics, Federal University of Sao Paulo, Brazil) L. Oliveira (Department of Biophysics, Federal University of Sao Paulo, Brazil) |
0362
Novel Aspects of Angiotensin II Signalling in Vascular Smooth Muscle
B Lassegue (Division of Cardiology, Emory University School of Medicine, USA) M Ushio-Fukai (Division of Cardiology, Emory University School of Medicine, USA) KK Griendling (Division of Cardiology, Emory University School of Medicine, USA) |
0492
Regulation of AT1 Receptor by 5' Leader Sequence RNA Binding Proteins.
K Sandberg (Departments of Medicine & Physiology, Georgetown University Medical Center, USA) K Krishnamurthi (Department of Physiology, Georgetown University Medical Center, USA) AD Verbalis (Department of Medicine, Georgetown University Medical Center, USA) K-Y Mok (Department of Physiology, Georgetown University Medical Center, USA) S Mulroney (Department of Physiology, Georgetown University Medical Center, USA) |
0679
Ligand contact points in the angiotensin receptors.
G Guillemette (Department of Pharmacology, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Canada) G Servant (Department of Cellular Molecular Pharmacology, University of California, San Francisco, USA) SA Laporte (Department of Cellular Biology, Duke University, North Carolina, USA) J Pérodin (Department of Pharmacology, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Canada) AA Boucard (Department of Pharmacology, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Canada) R Leduc (Department of Pharmacology, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Canada) E Escher (Department of Pharmacology, Faculty of Medicine, Université de Sherbrooke, Sherbrooke, Canada) |